Australia’s Race to Become the First Nation to Eradicate a Cancer
SYDNEY — Australia is currently on the frontline of a global medical milestone, aiming to become the first country in the world to eliminate cervical cancer.
With a target date set for 2035, the nation is leveraging a powerful "two-pronged" strategy of universal vaccination and advanced screening to relegate the disease to the history books.
A Generation Without the Burden
For many Australian families, the mission is deeply personal. Chrissy Walters, a mother from Toowoomba, was diagnosed with advanced cervical cancer just six months after the birth of her first child. Now facing a terminal diagnosis, she has spent over a decade undergoing grueling treatments.
However, her 12-year-old daughter represents a new era. In 2026, she reached the age for Australia’s school-based vaccination program—a key pillar in the government’s plan to ensure future generations never face her mother's ordeal.
The Strategy for Elimination
Australia’s success rests on two major public health initiatives:
The HPV Vaccine: Distributed in high schools to 12- and 13-year-olds, the vaccine targets the Human Papillomavirus (HPV), the primary cause of cervical cancer.
Australia was a global pioneer, launching the first national HPV program in 2007. Advanced Screening: In 2017, the country replaced traditional Pap smears with more accurate HPV-based cervical screening tests, which are now required only once every five years and offer a "self-collect" option to increase participation.
Key Milestones and Hurdles
According to the 2025 Cervical Cancer Elimination Progress Report, Australia is making historic strides:
Zero Cases in Youth: For the first time since records began in 1982, there were no cervical cancer cases diagnosed in women under age 25 in 2021.
Low Prevalence: The prevalence of high-risk HPV strains (16 and 18) plummeted to just 1.4% among screened women in 2024.
Despite these wins, challenges remain. Health officials are concerned by a slight dip in preventative care; HPV vaccine coverage among 15-year-olds dropped from a peak of 85.7% in 2020 to 79.5% in 2024.
Defining "Elimination"
In the medical community, "elimination" does not mean the disease will vanish entirely.
"Australia is at the forefront of this innovation," says Professor Karen Canfell, a lead researcher at the University of Sydney.
If successful, Australia will provide a blueprint for the rest of the world to follow, proving that with the right tools, a once-deadly cancer can be effectively controlled.
